Form 8-K - Current report:
SEC Accession No. 0001558370-20-000682
Filing Date
2020-02-11
Accepted
2020-02-11 17:00:46
Documents
14
Period of Report
2020-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20200205x8kb2f97c3.htm   iXBRL 8-K 35339
2 EX-99.1 ex-99d1.htm EX-99.1 15061
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 32576
  Complete submission text file 0001558370-20-000682.txt   219722

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20200205.xsd EX-101.SCH 3258
5 EX-101.LAB omer-20200205_lab.xml EX-101.LAB 15501
6 EX-101.PRE omer-20200205_pre.xml EX-101.PRE 10532
9 EXTRACTED XBRL INSTANCE DOCUMENT omer-20200205x8kb2f97c3_htm.xml XML 4624
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 20597902
SIC: 2834 Pharmaceutical Preparations